Safety and efficacy of Danqipiantan capsule for treatment of stroke: a systematic review

Be the first to review this product

$8.00

VAT Exempt

In stock

SKU

JTCM-484

Skip to the end of the images gallery

Skip to the beginning of the images gallery

Abstracts

To read the full abstract subscribe to the JCM online archive

Danqipiantan capsule (DQPTC) is a drug that has been recently licensed for the treatment of stroke in China. This review of the safety and efficacy of DQPTC for the ...

Overview

More Information
Author	Li Jiashen

Reviews

Write Your Own Review

* Orders shipped outside of Europe are eligible for VAT relief and will not be charged VAT.